Gastric Bypass Surgery: Clinical Trials

2 trials for Gastric Bypass Surgery, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 unknown. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Not yet recruiting 1, Unknown 1
Phase 31Unknown 1

Follow Gastric Bypass Surgery: new trials by email Literature Review of Gastric Bypass Surgery trials Research Report on Gastric Bypass Surgery

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anakinra for the Treatment of Postprandial Hypoglycemia in a Patient With Total Gastrectomy and End-Stage Renal Disease
Anakinra (interleukin-1 receptor antagonist), Placebo Comparator (0.9% NaCl) - Postprandial Hypoglycemia, End-stage Renal Disease (ESRD)
Phase 2Not yet recruitingMarc Donath12026-07-012026-05-12
The Effects of Probiotic Supplementation on the Results of Gastric Bypass Surgery
probiotic, Placebo - Gastric Bypass Surgery
Phase 2 / Phase 3UnknownNational Nutrition and Food Technology Institute502015-09-012016-03-15

Narrower conditions

Glucose Metabolism Disorders (1)  ·  Hypoglycemia (1)  ·  Inflammation (1)  ·  Kidney Failure, Chronic (1)

Broader conditions

Chronic Disease (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Renal Insufficiency (1)  ·  Renal Insufficiency, Chronic (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Interleukin 1 Receptor Antagonist Protein (1)  ·  Probiotics (1)  ·  Receptors, Interleukin-6 (1)

Sponsors

Marc Donath (1)  ·  National Nutrition and Food Technology Institute (1)

Countries

Iran (1)  ·  Switzerland (1)

Top investigators

Matthias Hepprich, PD Dr. med. (1)

Results publications

PMID 29725975, PMID 30612325

NIH funding

2025 (1)